Treatment with the tocolytic agents isoxsuprine or nifedipine was similarly effective in delaying delivery by 2 weeks among women who were admitted for preterm labour, according to a study presented at the RCOG World Congress 2018.
Sentinel lymph node (SLN) mapping and biopsy is noninferior to systematic lymphadenectomy in detecting LN metastases with <5-percent false negative rate, says Timothy Lim, head of the Department of Gynaecologic Oncology at KK Women’s and Children’s Hospital and associate professor at Yong Loo Lin School of Medicine, National University Singapore.
It appears that the WA Gynaescope technique of in-bag morcellation (IBM) is safe, reproducible and a valuable addition to current methods of specimen retrieval during minimal invasive surgery, according to a study presented at the 2018 World Congress of the Royal College of Obstetricians and Gynaecologists (RCOG 2018) held recently in Singapore.
In patients with cervical carcinoma, lymph node enlargement appears to be common in those with a small cell pathology, while having a stage III disease may lead to involvement of the paraaortic lymph nodes, according to a recent study presented at the recently concluded 2018 World Congress of the Royal College of Obstetricians and Gynaecologists (RCOG 2018) held in Singapore.
A high daily dose of vitamin D (4,000 IU/day) resulted in a reduction in vitamin D deficiency in pregnant women, coupled with a lower risk of preterm births and low birth weight in their newborns, according to a study presented at RCOG 2018.
One third of women who have been in a relationship have experienced some form of physical and/or sexual violence by their intimate partner in their lifetime, and pregnant women are particularly vulnerable to domestic violence and abuse (DVA), said President of RCOG Professor Lesley Regan at the recent RCOG World Congress 2018 in Singapore.
First-hand accounts and patient narratives are important in improving the quality of domestic abuse education in medical schools, according to a UK study presented at the recently concluded 2018 World Congress of the Royal College of Obstetricians and Gynaecologists (RCOG 2018) held in Singapore.
Several strategies have been proposed to help manage the adverse events (AEs) that emerged during the BEACON CRC trial which assessed the effect of encorafenib plus cetuximab in patients with BRAF V600E mutant metastatic colorectal cancer (mCRC) who had progressed after one or two prior regimens.